QIAO Gui-bin, CHENG Hua. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007
|
Citation:
|
QIAO Gui-bin, CHENG Hua. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007
|
QIAO Gui-bin, CHENG Hua. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007
|
Citation:
|
QIAO Gui-bin, CHENG Hua. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007
|
DownLoad: